ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 112 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 3.04 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $14,143,000 | 1.69% |
| CM Management, LLC | 250,000 | $1,423,000 | 1.59% |
| Ally Bridge Group (NY) LLC | 360,000 | $2,048,000 | 1.35% |
| EcoR1 Capital, LLC | 6,184,861 | $35,192,000 | 1.04% |
| Cormorant Asset Management, LP | 1,547,181 | $8,803,000 | 0.62% |
| K2 PRINCIPAL FUND, L.P. | 605,419 | $3,445,000 | 0.40% |
| FEDERATED HERMES, INC. | 3,626,818 | $20,637,000 | 0.06% |
| PDT Partners, LLC | 68,754 | $391,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 355,612 | $2,023,000 | 0.05% |
| Virtus ETF Advisers LLC | 15,660 | $89,000 | 0.04% |